Transplantation of isolated hepatocytes has been proposed to compensate for essential functions lacking in liver failure or for genetic defects that alter a specific liver metabolic pathway. Hepatocyte utilization for these purposes would be facilitated with a reliable, reproducible, and effective method of long-term hepatocyte storage. We have recently developed a simple new system for cryopreservation of hepatocytes that encapsulates alginate microspheres and maintains liver-specific function. The aim of this study was to elucidate the transport and drug-metabolizing enzyme activities of cryopreserved microencapsulated hepatocytes stored for a long time. Morphological examinations showed there is no apparent injury of the hepatocytes during cryopreservation processes. A drug-metabolizing enzyme (testosterone 6β-hydroxylase, a specific probe for CYP3A2) and drug transport activities [salicylate, allopurinol, and prostaglandin E 2 (PGE 2 ), typical substrates of rOat2] in cryopreserved microencapsulated hepatocytes were maintained up to 120 days. Our results thus demonstrate for the first time that cryopreservation of primary rat hepatocytes by the encapsulation technique allows long-term retention of drug metabolism and drug transport activities.
INTRODUCTION
cerning liver cell transplantation have been tantalizingly slow. Compared to intact livers, cryopreserved hepatocytes may be useful in an emergency because they can Liver transplantation is considered the only effective treatment for many intractable hepatic disorders. Be-be prepared for the rescue of patients with immediate liver failure. cause the demand for transplantable livers is outpacing the supply of donated cadaver organs and resulting in Cryopreservation has been established as a standard technique for long-term hepatocyte storage (1,8). Be-longer waiting times and increased mortality among prospective recipients (United Network for Organ Sharing: cause the current methods severely damage the cells (12,30), many investigators have been attempting to de-http://www.unos.org/), it is necessary to develop artificial liver support systems such as a bioreactor (2,9,32, velop new techniques for the long-term storage of hepatocytes (11, 25, 31) . In this respect, many investigators 39) and methods of hepatocyte transplantation. Many investigators have evaluated transplantation of isolated have demonstrated that programmable freezers are effective for the maintenance of cell functions (21, 22, 35) ; liver cells as a less invasive alternative to whole organ transplantation (3,5,10, 14, 27, 36, 37) . Other studies and however, novel and simple methods to maintain cell viability and liver functions need to be developed. clinical experience indicate that liver cell transplantation is potentially useful for the treatment of hepatic disor-
We have recently reported a novel method of cryopreservation of rat hepatocytes by using an encapsula-ders and a bridge for patients with liver failure awaiting transplantation (3,5,10, 14, 27, 36, 37) . Despite these po-tion technique (4). Because drug metabolism and drug transport are major roles of the liver, it is necessary to tential advantages, however, various applications con-68 KOIZUMI ET AL. elucidate whether cryopreserved microencapsulated he-Oriental Yeast Co. Ltd, Tokyo, Japan) and water ad libitum. This study was approved by the Committee on Eth-patocytes retain such liver functions even under a long period of storage.
ics regarding the Care and Use of Laboratory Animals at Showa University. All surgical operations were per-In the present study, we investigated and focused on the drug-metabolizing activity and drug transport func-formed under anesthesia. tion of cryopreserved microencapsulated rat hepato-Hepatocytes Isolation and Cell Viability cytes. Our results indicate that the cryopreserved microencapsulated hepatocytes retain such functions for at Rat hepatocytes were harvested by in situ two-step least 120 days.
EDTA/collagenase digestion, as previously described by Seglen (33). Their viability was measured by the trypan MATERIALS AND METHODS blue exclusion test as described by Mahler (25 Cryopreservation of Microencapsulated Hepatocytes were used in the present study and were purchased from Saitama Experimental Animals Supply Co., Ltd. (Sai-Isolated encapsulated rat hepatocytes was immersed in a cryopreservation medium consisting of 80% DMEM, tama, Japan). The animals were housed under a 12-h light/dark cycle for at least 1 week prior to surgery and 10% FBS, and 10% dimethyl sulfoxide (DMSO). Aliquots of encapsulated hepatocytes were immediately im-given free access to standard laboratory rat chow (MF glycerol, and 100 µM phenylmethylsulfonyl fluoride.
The sample was used for determining testosterone 6βhydroxylase (17) . The protein concentration was estimersed in liquid nitrogen and stored until use. The enmated by the method of Lowry (24) with bovine serum capsulated hepatocytes were thawed by placing in a albumin as the standard. water bath at 37°C. Encapsulated hepatocytes were Testosterone 6β-Hydroxylase Activity washed with DMEM containing 10% FBS, and aliquots were transferred to a DMEM culture medium.
Testosterone 6β-hydroxylase activity was measured by the method of Graves (17) . Microsomal preparation Ultrastructural Examination (20 µg) was incubated with 25 µM [ 14 C]testosterone and 1 mM NADPH in a final volume of 100 µl of 50 mM Epon-embedded capsules were sectioned for ultrastructual examination. Ultrathin sections were stained HEPES buffer (pH 7.6) containing 15 mM MgCl 2 and Values for catalytic activity are derived from duplicate incubations performed as described previously (17) . Parentheses indicate the percentage of activity at day 0. 0.1 mM EDTA. The incubation was carried out for 20 min at 37°C, and quenching was performed by adding 50 µl tetrahydrofuran. Aliquots of 50 µl were spotted on the preabsorbant loading zone of a TLC plate (J.T. Baker, NJ, USA), and developed twice in chloroform/ ethylacetate (1:4). Metabolites were localized by autoradiography. The radioactive areas on the plates were scraped into scintillation vials with Aquazol-2, and metabolites were quantified by liquid scintillation counting.
Transport Experiments
The cryopreserved encapsulated hepatocytes (1 × 10 6 cells) were incubated at 37°C with [ 14 C]salicylate, [ 14 C]allopurinol, or [ 3 H]PGE 2 in PBS. Uptake was stopped by addition of ice-cold PBS at designated time periods, and the cells were washed at least five times with 0.5 ml of ice-cold PBS. The cells were lysed with 250 µl of 0.5 N NaOH, and 5.0 ml of Aquasol-2 was added for liquid scintillation counting.
Statistical Analysis
The statistical analysis was performed by the unpaired Student's t-test (p < 0.05) or one-way analysis of patocyte cryopreservation capable of maintaining he-their hepatic function (urea synthesis) (4). However, it is not clear at this time whether long-term storage of cryopreserved microencapsulated hepatocytes can mediate the transport of drugs.
It is known that hepatocytes are easily damaged by freeze-thaw cycles (12,30). To elucidate whether cryopreserved microencapsulated hepatocytes are damaged during long-term storage, firstly, morphological analysis was investigated with a transmission electron microscopy. The result is shown in Figure 1 . As shown in Figure 1A , low-power examination of a single spheroid with an alginate bead revealed normal-appearing hepatocytes with normal nuclear and cytoplasmic morphology. Under the high-power examination (Fig. 1B) , many mitochondria and golgi bodies were also visible in the encapsulated hepatocytes. Cryopreserved microencapsulated hepatocytes retained their viability compared with the data generated using the cryopreserved hepatocytes (Table 1 ). These results indicate that there is no severe damage in the structure and viability of cryopreserved microencapsulated hepatocytes during freeze-thaw cycles (38) .
Drug transport across the hepatocyte plasma membrane is a key step for hepatic drug clearance. To date, several distinct multispecific organic anion transporters such as organic anion transporting polypeptides (Oatps [Slc21a]) and organic anion transporters (Oat[Slc22a]) have been isolated from rat liver (13, 19, 20) . These transporters are localized at either sinusoidal or calalicular membrane sites of the liver. Among the Oat family, rOat1, 2, and 3 are predominantly expressed in the kidney, whereas rOat2 is abundantly expressed in the liver (20, 29, 34) . Therefore, rOat2 is considered to be a key molecule in hepatic handling of drugs. We have recently demonstrated that cryopreserved microencapsulated hepatocytes expresse rOat2 mRNA and its protein for up to 50 days (4). Based on these findings, we subsequently examined whether rOat2 protein is also detected in cryo- Immunostaining take experiments were started by adding radiolabeled substrates and were terminated by adding ice-cold buffer. Time-depen-with anti-rOat2 antibody was completely diminished by dent uptake experiments were also performed in the presence incubating normal rat serum ( Fig. 2A) served that at least catalytic activity of CYP3A2 in cryopreserved microencapsulated hepatocytes is maintained for up to 120 days. We also observed that the genes REFERENCES coding for CYP3A2, 3A9, and 3A23 were detected up 
